Evidence map›Paper›PMID 29132234›Full record

ReviewThe journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians2019

Upcycling umbilical cords: bridging regenerative medicine with neonatology.

Alvaro Moreira, Yasmeen Alayli, Saloni Balgi, Caitlyn Winter, Samuel Kahlenberg, Shamimunisa Mustafa, Peter Hornsby

Abstract readReview
In one paragraph

Review in The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alvaro Moreiraa Division of Neonatology, Department of Pediatrics , University of Texas Health Science Center , San Antonio , TX , USA.ORCID http://orcid.org/0000-0003-3455-6608
Yasmeen Alaylia Division of Neonatology, Department of Pediatrics , University of Texas Health Science Center , San Antonio , TX , USA.
Saloni Balgia Division of Neonatology, Department of Pediatrics , University of Texas Health Science Center , San Antonio , TX , USA.
Caitlyn Wintera Division of Neonatology, Department of Pediatrics , University of Texas Health Science Center , San Antonio , TX , USA.
Samuel Kahlenberga Division of Neonatology, Department of Pediatrics , University of Texas Health Science Center , San Antonio , TX , USA.
Shamimunisa Mustafaa Division of Neonatology, Department of Pediatrics , University of Texas Health Science Center , San Antonio , TX , USA.
Peter Hornsbyb Department of Cellular and Integrative Physiology , University of Texas Health Science Center , San Antonio , TX , USA.

Funding

Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthKL2TR001118 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, DOUGHERTY, DONALD M · 2013 to 2017
$3.4M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthKL2TR000118 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A · 2012 to 2013
$757k
Institute for Integration of Medicine & Science: A Partnership to Improve HealthTL1TR001119 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, DOUGHERTY, DONALD M · 2013 to 2017
$640k
NCATS NIH HHS KL2 TR000118NCATS NIH HHS KL2 TR001118NCATS NIH HHS TL1 TR001119NCATS NIH HHS UL1 TR001120
6 · The paper itself

Abstract

Preterm birth is a major health concern that affects 10% of all worldwide deliveries. Many preterm infants are discharged from the hospital with morbidities that lead to an increased risk for neurodevelopmental impairment, recurrent hospitalizations, and life-long conditions. Unfortunately, the treatment of these conditions is palliative rather than curative, which calls for novel and innovative strategies. Progress in regenerative medicine has offered therapeutic options for many of these conditions. Specifically, human umbilical cord mesenchymal stem cells (MSCs) and cord blood (UCB) cells have shown promise in treating adult-onset diseases. Unlike bone-marrow and embryonic derived stem cells, umbilical cord-derived cells are easily and humanely obtained, have low immunogenicity, and offer the potential of autologous therapy. While there are several studies to uphold the efficacy of umbilical cord MSCs in adult therapies, there remains an unmet need for the investigation of its use in treating neonates. The purpose of this review is to provide a summary of current information on the potential therapeutic benefits and clinical applicability of umbilical cord MSCs and UCB cells. Promising preclinical studies have now led to a research movement that is focusing on cell-based therapies for preterm infants.

Indexed as

Cord Blood Stem Cell TransplantationHumansInfant, NewbornInfant, PrematureInfant, Premature, DiseasesMesenchymal Stem CellsMesenchymal Stem Cell TransplantationNeonatologyRegenerative MedicineUmbilical CordWharton JellyBronchopulmonary dysplasiahypoxic ischemic encephalopathymesenchymal stem cellsumbilical cord blood

Identifiers

PMID29132234
PMCPMC6175672

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.